Wells Fargo’s Safeguard Scientifics, Inc. SFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,144
| Closed | -$2.47K | – | 7824 |
|
|
2023
Q4 | $2.47K | Buy |
3,144
+1,905
| +154% | +$1.92K | ﹤0.01% | 6068 |
|
|
2023
Q3 | $1.24K | Sell |
1,239
-1
| -0.1% | -$1 | ﹤0.01% | 6167 |
|
|
2023
Q2 | $2.04K | Buy |
1,240
+5
| +0.4% | +$9 | ﹤0.01% | 6205 |
|
|
2023
Q1 | $2.13K | Buy |
1,235
+1
| +0.1% | +$3 | ﹤0.01% | 6215 |
|
|
2022
Q4 | $3.83K | Buy |
1,234
+3
| +0.2% | +$10 | ﹤0.01% | 5836 |
|
|
2022
Q3 | $4K | Sell |
1,231
-133
| -10% | -$534 | ﹤0.01% | 6010 |
|
|
2022
Q2 | $5K | Buy |
1,364
+100
| +8% | +$418 | ﹤0.01% | 6041 |
|
|
2022
Q1 | $6K | Sell |
1,264
-6,700
| -84% | -$40.6K | ﹤0.01% | 6439 |
|
|
2021
Q4 | $59K | Sell |
7,964
-86
| -1% | -$672 | ﹤0.01% | 5889 |
|
|
2021
Q3 | $72K | Sell |
8,050
-40,388
| -83% | -$323K | ﹤0.01% | 5504 |
|
|
2021
Q2 | $376K | Sell |
48,438
-36,912
| -43% | -$252K | ﹤0.01% | 4761 |
|
|
2021
Q1 | $582K | Sell |
85,350
-18,657
| -18% | -$135K | ﹤0.01% | 4599 |
|
|
2020
Q4 | $663K | Buy |
104,007
+22,632
| +28% | +$141K | ﹤0.01% | 4322 |
|
|
2020
Q3 | $445K | Sell |
81,375
-2,537
| -3% | -$15.1K | ﹤0.01% | 4429 |
|
|
2020
Q2 | $587K | Buy |
83,912
+28,610
| +52% | +$181K | ﹤0.01% | 4206 |
|
|
2020
Q1 | $307K | Buy |
55,302
+994
| +2% | +$8.88K | ﹤0.01% | 4401 |
|
|
2019
Q4 | $596K | Buy |
54,308
+31,579
| +139% | +$361K | ﹤0.01% | 4232 |
|
|
2019
Q3 | $258K | Buy |
22,729
+1,326
| +6% | +$15.8K | ﹤0.01% | 4808 |
|
|
2019
Q2 | $258K | Sell |
21,403
-3,082
| -13% | -$36.1K | ﹤0.01% | 4823 |
|
|
2019
Q1 | $265K | Buy |
24,485
+3,851
| +19% | +$39K | ﹤0.01% | 4679 |
|
|
2018
Q4 | $178K | Sell |
20,634
-1,410
| -6% | -$12.3K | ﹤0.01% | 4991 |
|
|
2018
Q3 | $206K | Sell |
22,044
-567
| -3% | -$6.16K | ﹤0.01% | 4986 |
|
|
2018
Q2 | $290K | Sell |
22,611
-1,581
| -7% | -$20.4K | ﹤0.01% | 4826 |
|
|
2018
Q1 | $296K | Buy |
24,192
+8,964
| +59% | +$109K | ﹤0.01% | 4750 |
|
|
2017
Q4 | $170K | Sell |
15,228
-6,450
| -30% | -$82.6K | ﹤0.01% | 5046 |
|
|
2017
Q3 | $289K | Buy |
21,678
+1,545
| +8% | +$19K | ﹤0.01% | 4699 |
|
|
2017
Q2 | $240K | Buy |
20,133
+4,182
| +26% | +$49.2K | ﹤0.01% | 4667 |
|
|
2017
Q1 | $203K | Buy |
15,951
+791
| +5% | +$9.96K | ﹤0.01% | 4809 |
|
|
2016
Q4 | $203K | Buy |
15,160
+6,219
| +70% | +$76.7K | ﹤0.01% | 4773 |
|
|
2016
Q3 | $116K | Buy |
8,941
+1,413
| +19% | +$18.7K | ﹤0.01% | 4826 |
|
|
2016
Q2 | $94K | Sell |
7,528
-14,048
| -65% | -$188K | ﹤0.01% | 4877 |
|
|
2016
Q1 | $285K | Buy |
21,576
+3,838
| +22% | +$48.3K | ﹤0.01% | 4197 |
|
|
2015
Q4 | $257K | Buy |
17,738
+11
| +0.1% | +$178 | ﹤0.01% | 4299 |
|
|
2015
Q3 | $276K | Sell |
17,727
-1,907
| -10% | -$34.2K | ﹤0.01% | 4284 |
|
|
2015
Q2 | $382K | Buy |
19,634
+5,902
| +43% | +$108K | ﹤0.01% | 4253 |
|
|
2015
Q1 | $248K | Buy |
13,732
+109
| +0.8% | +$2.02K | ﹤0.01% | 4323 |
|
|
2014
Q4 | $270K | Sell |
13,623
-18,591
| -58% | -$358K | ﹤0.01% | 4275 |
|
|
2014
Q3 | $593K | Sell |
32,214
-2,036
| -6% | -$40.2K | ﹤0.01% | 3790 |
|
|
2014
Q2 | $712K | Buy |
34,250
+14,054
| +70% | +$283K | ﹤0.01% | 3727 |
|
|
2014
Q1 | $447K | Sell |
20,196
-24,492
| -55% | -$487K | ﹤0.01% | 3945 |
|
|
2013
Q4 | $899K | Sell |
44,688
-14,852
| -25% | -$263K | ﹤0.01% | 3480 |
|
|
2013
Q3 | $935K | Sell |
59,540
-22,496
| -27% | -$346K | ﹤0.01% | 3400 |
|
|
2013
Q2 | $1.32M | Buy |
+82,036
| New | +$1.3M | ﹤0.01% | 3091 |
|
Other funds holding SFE
CP
RA
FWM
HNB
Wells Fargo's SFE Position: Q1 2024 in Review
Wells Fargo sold out of Safeguard Scientifics, Inc. (SFE) in Q1 2024, closing a stake of 3,144 shares — an estimated $2.47K sold.
Wells Fargo first reported a position in SFE in Q2 2013 and held it in 43 quarters. The position peaked at $1.32M in Q2 2013. 4 funds tracked by Wall St. Rank hold SFE as of Q1 2024.
- Wells Fargo reported no remaining Safeguard Scientifics, Inc. position as of Q1 2024 after selling out during the quarter.
- Wells Fargo sold 3,144 Safeguard Scientifics, Inc. shares in Q1 2024, an estimated $2.47K.
- Wells Fargo first reported a position in Safeguard Scientifics, Inc. in Q2 2013 and held it in 43 quarters.
- Wells Fargo's Safeguard Scientifics, Inc. position peaked at $1.32M in Q2 2013.
- 4 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q1 2024.
Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.